iTRAQ Quantitative Analysis of Multidrug Resistance Mechanisms in Human Gastric Cancer Cells

Journal of Biomedicine and Biotechnology
doi 10.1155/2010/571343
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

A Review of Research Progress in Multidrug-Resistance Mechanisms in Gastric Cancer

OncoTargets and Therapy
OncologyPharmacology
2020English

iTRAQ-based Quantitative Proteomic Analysis of Yamanaka Factors Reprogrammed Breast Cancer Cells

Oncotarget
Oncology
2017English

miR-625 Reverses Multidrug Resistance in Gastric Cancer Cells by Directly Targeting ALDH1A1

Cancer Management and Research
Oncology
2019English

Quantitative Proteomic Analysis Reveals Up-Regulation of Caveolin-1 in FOXP3-overexpressed Human Gastric Cancer Cells

Scientific Reports
Multidisciplinary
2017English

Constituents and Anti-Multidrug Resistance Activity of Taiwanofungus Camphoratus on Human Cervical Cancer Cells

Molecules
Organic ChemistryMolecular MedicineAnalytical ChemistryTheoretical ChemistryPharmaceutical ScienceMedicineDrug DiscoveryChemistryPhysical
2019English

Multidrug Resistance in Prostate Cancer

Oncology Research and Treatment
Cancer ResearchOncologyHematology
2003English

Furosemide Reverses Multidrug Resistance Status in Bladder Cancer Cells in Vitro

Journal of Clinical Pathology
MedicineForensic MedicinePathology
2006English

Expression of Multidrug Resistance Proteins and Accumulation of Cisplatin in Human Non-Small Cell Lung Cancer Cells

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2005English

Crown Ethers Reverse P-Glycoprotein-Mediated Multidrug Resistance in Cancer Cells

Scientific Reports
Multidisciplinary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy